Compare FLL & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLL | PYPD |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United States | Israel |
| Employees | N/A | 75 |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.5M | 85.1M |
| IPO Year | 2014 | 2014 |
| Metric | FLL | PYPD |
|---|---|---|
| Price | $2.75 | $4.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $4.00 | ★ $12.25 |
| AVG Volume (30 Days) | ★ 170.3K | 48.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $302,376,000.00 | N/A |
| Revenue This Year | $7.54 | N/A |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.53 | N/A |
| 52 Week Low | $2.02 | $2.44 |
| 52 Week High | $4.95 | $5.12 |
| Indicator | FLL | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 54.58 | 51.61 |
| Support Level | $2.23 | $4.15 |
| Resistance Level | $2.80 | $4.56 |
| Average True Range (ATR) | 0.18 | 0.24 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 54.93 | 65.96 |
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins. Geographically, it operates in United States.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.